Evidence map›Paper›PMID 29049270›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity.

Joanna Kocot, Piotr Dziemidok, Małgorzata Kiełczykowska, Anna Hordyjewska, Grzegorz Szcześniak, Irena Musik

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Plasma Lipocalin-2 and Adiponectin are Affected by Obesity Rather Than Type 2 Diabetes Mellitus per se.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  11. Article
  12. The Latest Insights into Adipokines in Diabetes.Journal of clinical medicine · 2019
    Article
  13. Review
  14. Review
  15. IRISIN AND CHEMERIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joanna KocotChair and Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland.
Piotr DziemidokInstitute of Public Health, Pope John Paul II State School of Higher Education, Biała Podlaska, Poland.
Małgorzata KiełczykowskaChair and Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland.
Anna HordyjewskaChair and Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland.
Grzegorz SzcześniakDiabetology Ward, Institute of Rural Health, Lublin, Poland.
Irena MusikChair and Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland.
Medical University of Lublin · PLInstytut Medycyny Wsi im. Witolda Chodźki · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The fast pace of life, promoting fast food consumption and low physical activity, has resulted in obesity and/or diabetes as being serious social problems. The aim of the present study was to evaluate concentrations of selected adipokines (leptin, adiponectin, resistin, and visfatin) and to assess the leptin/adiponectin ratio in plasma of type 2 diabetes (T2D) patients in relation to degree of obesity. MATERIAL AND METHODS The study comprised 92 T2D subjects divided into 4 groups according to BMI value - I (normal body weight), II (overweight), III (obesity), and IV (severe obesity) - and 20 healthy volunteers (control group). Each group was divided into male and female subgroups. Plasma concentrations of adipokines were determined by enzyme-linked immunosorbent assay. RESULTS In women, leptin concentration was significantly higher in group IV, whereas in men it was higher in groups III and IV than in the control group and groups I and II. Irrespective of sex, a significant decrease in adiponectin level was observed in group III vs. CONTROL: There was no significant difference in resistin levels. In women visfatin was markedly enhanced in group III, whereas in men in groups II, III and IV vs. CONTROL: Leptin/adiponectin ratio was increased in groups III and IV vs. control in women, whereas in men vs. both control and group I. CONCLUSIONS The obese type 2 diabetic patients presented a disturbed adipokine profile, which seems to be an important link between obesity and T2D. The future studies concerning the question if regulating of adipokines' concentrations could be a promising approach for managing metabolic disorders seem to be well-grounded.

Indexed as

AdipokinesAdiponectinAdultBody Mass IndexCase-Control StudiesDiabetes Mellitus, Type 2FemaleHumansLeptinMaleMiddle AgedNicotinamide PhosphoribosyltransferaseObesityOverweightResistinAdipokinesAdiponectinLeptinNicotinamide PhosphoribosyltransferaseResistin

Identifiers

PMID29049270
PMCPMC5659140
OpenAlexW2765134383

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.